Specialty testing platforms utilize breakthrough technologies like liquid biopsies, advanced AI imaging analysis, and sophisticated genetic sequencing that can detect health issues years before conventional testing. For example, Galleri can identify cancer signals from over 50 cancer types through blood analysis, while Cleerly uses AI to assess coronary artery disease risk with precision impossible through standard stress testing. These platforms provide insights that simply aren't available through traditional medical testing.

Most specialty testing platforms are considered preventive or elective and typically aren't covered by traditional insurance plans. However, the insights gained often provide invaluable early detection capabilities that can prevent costly future medical interventions. Our team provides transparent pricing information and helps you understand the investment required for each testing platform during your consultation.

Testing frequency varies based on the specific platform, your risk factors, and health goals. Cancer screening tests like Galleri may be recommended annually, while continuous glucose monitoring might be used for shorter intensive periods. Dr. Winnard provides personalized recommendations based on your individual health profile and optimization objectives.

Specialty testing platforms complement rather than replace conventional medical care and routine health screenings. These advanced diagnostics provide additional insights that enhance your overall health monitoring strategy. Dr. Winnard coordinates results with your other healthcare providers when appropriate to ensure comprehensive care coordination.

We partner exclusively with established, clinically-validated testing platforms that meet rigorous scientific standards. All specialty labs we work with have published research supporting their accuracy and clinical utility. Dr. Winnard provides expert interpretation of results and guides appropriate follow-up when findings require additional evaluation or intervention.